GlassScriptPhysician profile
Kelsey E Darden
NPI 1144716945
$6,873.03
in general payments reported to CMS, 2019-2025
36 companies · $1,256 in 2025
The $1,256 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $948 · 2022: $1,183 · 2023: $1,551 · 2024: $1,936 · 2025: $1,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,742.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,777.69 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,054.13 | 2021-2025 | Farxiga, Wainua, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $569.98 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $558.27 | 2021-2025 | Camzyos, Eliquis |
| Pfizer INC. | $473.75 | 2021-2025 | |
| Amgen INC. | $376.74 | 2021-2025 | Repatha, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $262.61 | 2021-2024 | Verquvo |
| Novo Nordisk INC | $249.89 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $235.05 | 2023 | Mitraclip, Navitor, Aveir |
| Alnylam Pharmaceuticals INC. | $174.95 | 2023-2025 | Onpattro |
| Biotronik INC. | $168.79 | 2021 | |
| Boston Scientific Corporation | $150.87 | 2022-2024 | Watchman Flx |
| Kiniksa Pharmaceuticals International, Plc | $119.58 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.66 | 2022-2025 | Jardiance |
| Philips North America LLC | $51.57 | 2023-2024 | (Ck4) Mcot |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $47.53 | 2021-2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $44.41 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $43.14 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $41.61 | 2021-2024 | Xarelto |
| Amarin Pharma, INC. | $41.50 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $36.76 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $34.98 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $29.64 | 2025 | Attruby |
| Abbvie INC. | $29.17 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.59 | 2025 | Trintellix |
| Verona Pharma, INC. | $21.53 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $19.66 | 2025 | Symbravo |
| Regeneron Healthcare Solutions, INC. | $19.07 | 2022 | |
| Glaxosmithkline, LLC. | $18.43 | 2025 | Arexvy, Shingrix |
| Lilly USA, LLC | $17.33 | 2025 | Zepbound, Mounjaro |
| Atricure, INC. | $16.86 | 2023 | |
| Exact Sciences Corporation | $13.70 | 2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $13.09 | 2024 | Korlym |
| Esperion Therapeutics, INC. | $12.45 | 2022 | |
| Cvrx, INC. | $12.28 | 2025 | Barostim Neo System |
| Phathom Pharmaceuticals, INC. | $10.77 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Darden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.